
COURSE CREDITS & HOURS
16 AMA PRA Category 1 Credits™16 ANCC Contact Hours
COURSE FEES
TARGET AUDIENCE
PROGRAM TOPICS
-
Discuss GOLD Guidelines for Staging COPD
- Discuss GOLD 2023 Guidelines for COPD management.
- Discuss the ACCP and Canadian Thoracic Society published guidelines for prevention of acute exacerbations of COPD.
- Discuss the data that shaped these guidelines as related to: 1. Medication Recommendations, 2. Non-medication Recommendations.
- Discuss data on surgical and non-surgical lung volume reduction in patients with COPD.
- Discuss data on NIV for stable and acute COPD management.
- Discuss New areas of investigation.
-
Asthma
- Discuss the prevalence and economic impact of asthma.
- Examine the pathophysiology of asthma.
- Discuss strategies for management of asthma patients with acute respiratory failure.
- Discuss expert consensus recommendations and application of these recommendations for assessing asthma control and disease management.
- Discuss updated expert consensus recommendations for long-term asthma management.
- Examine data on recently FDA-approved medications and bronchoscopic interventions used to treat severe persistent asthma.
-
Pulmonary Nodules and Lung Cancer Screening: Understanding and Applying the Society Recommendations
- Describe characteristics of pulmonary nodules that influence clinical suspicion for benign versus malignant.
- Discuss the Fleischner Society Guideline recommendations for following incidental pulmonary nodules noted on CT scans of the chest.
- Discuss Lung Cancer Screening Guidelines.
- Discuss Lung-RADS: the structured reporting system for interpretation of lung cancer screening CT examinations. Understand the difference in the Fleischner Guidelines and Lung Cancer Screening guidelines as related to nodule management.
- Discuss diagnosis and staging of lung cancer.
- Brief discussion of lung cancer treatment.
-
Acute Hypoxic Respiratory Failure and Acute Respiratory Distress Syndrome Clinical Update
- Review updated definition of ARDS.
- Discuss risk factors for developing ARDS as well as the differential diagnosis of patients presenting with acute hypoxic respiratory failure and bilateral pulmonary infiltrates.
- Examine data on the use of non-invasive ventilation and high flow nasal cannula for management of patients with hypoxic respiratory failure. Recognize clinical parameters suggesting failure of these modes of respiratory support.
- Understand the current recommendations regarding mechanical ventilation and management of patients with ARDS.
- Discuss the benefits and how to implement alternative treatments in patients with severe ARDS including: prone positioning, ECMO, paralytics, and vasodilators.
-
Pulmonary Embolism: Treating Patients Based on Risk Stratification, Evidence-Based Guidelines
- Discuss the Risk Stratification for Acute Pulmonary Embolism.
- Identify Clinical Tools, Radiological Imaging, and Laboratory Markers Used in Risk Stratification of Acute Pulmonary Embolism.
- Discuss Current ACCP Recommendations for Treatment of Acute Pulmonary Embolism.
- Discuss Data on Treatment Outcomes of Patients with High and Intermediate Risk Acute Pulmonary Embolism Treated with Thrombolysis, Catheter-Directed Thrombolysis, and Standard Anticoagulation.
- Discuss Data on Long-Term Follow-up from Patients with High and Intermediate Risk PE Treated with Thrombolysis versus Standard Anticoagulation.
- Review Current ACCP Recommendations for Duration of Treatment of Acute Pulmonary Embolism.
-
Sleep Apnea Treatment Options: PAP, PACERS, and Beyond
- Discuss the clinical benefit of weight loss and positional sleep therapy as treatment for OSA.
- Discuss data on medical interventions as related to treatment for OSA.
- Discuss data on Provent nasal device as related to treatment of OSA.
- Discuss data on dental devices as related to treatment for OSA.
- Discuss data on various surgical interventions as related to treatment of OSA.
- Discuss data on use of upper-airway stimulators for treatment of sleep apnea.
- Discuss data on use of diaphragm pacing in patients with central sleep apnea.
-
Interstitial Lung Disease Part 1: Idiopathic Pulmonary Fibrosis and Sarcoid
- Discuss the broad differential diagnosis of diffuse parenchymal lung disease.
- Discuss the ATS/ERS diagnostic criteria for IPF and CT findings characteristic of IPF.
- Understand the various clinical measures predictive of survival in IPF.
- Discuss data that resulted in FDA approval for two drugs for treatment of IPF.
- Discuss the ATS/ERS guidelines for treatment of IPF.
- Understand the clinical presentation of pulmonary sarcoidosis.
- Discuss the ERS clinical practice guidelines for treatment of sarcoidosis as related to organ involvement.
-
Interstitial Lung Disease Part 2: Hypersensitivity Pneumonitis and Non-Cystic Fibrosis Bronchiectasis
- Discuss ATS/ERS practice guidelines for diagnosis and management of hypersensitivity pneumonitis.
- Examine CT findings for fibrotic and non-fibrotic HP.
- Discuss the pathogenesis of non-cystic fibrosis bronchiectasis.
- Explain the work-up to determine the etiology of non-CF bronchiectasis.
- Discuss how to manage patients with non-CF bronchiectasis.
- Discuss management strategies in patients with acute exacerbations of non-CF bronchiectasis.
- Venovenous Extracorporeal Membrane Oxygenation
- Hypertensive Emergency
- Cardiac Arrest
- ARF and Oxygen
- Climate Change and Sepsis
- Acute Liver Failure
- Fluid Responsiveness in Shock 2024
- Critical Care below the Diaphragm








































































